Ipamorelin is a synthetic pentapeptide that has been widely studied for its selective action on growth hormone (GH) release through stimulation of the ghrelin receptor in the pituitary gland. Unlike some earlier growth hormone secretagogues, Ipamorelin is known for its targeted mechanism, which aims to enhance pituitary sensitivity while minimizing effects on other hormonal pathways such as cortisol or prolactin.